Medicare Enrolled
Dr. Vipin Ramprasad Lohiya, M.D.
Hematology & Oncology · Fayetteville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lohiya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lohiya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lohiya
Dr. Vipin Ramprasad Lohiya is a hematology & oncology specialist in Fayetteville, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Lohiya performed 119,307 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lohiya received a total of $10,747 from 67 pharmaceutical and/or device companies across 474 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lohiya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 7% volume in GA
$10,747 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗119,307
Medicare services
Top 7% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 35,200 | $41 | $110 |
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
20,460 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 20,220 | $18 | $44 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
19,042 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,753 | $0 | $0 |
| Iron infusion (Monoferric) | 3,600 | $16 | $65 |
| Injection, leucovorin calcium, per 50 mg | 2,225 | $3 | $9 |
| Injection, atropine sulfate, 0.01 mg | 1,960 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,870 | $1 | $5 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,664 | $2 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,408 | $8 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
782 | $95 | $260 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
693 | $22 | $118 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
653 | $100 | $525 |
| Injection, granisetron hydrochloride, 100 mcg | 650 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
527 | $12 | $82 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
513 | $11 | $60 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
456 | $76 | $450 |
| Injection, irinotecan, 20 mg | 424 | $2 | $6 |
| Cyclophosphamide, 100 mg | 368 | $14 | $70 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
270 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
237 | $63 | $168 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
180 | $1 | $2 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
175 | $49 | $250 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
171 | $174 | $550 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
164 | $26 | $126 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
152 | $43 | $218 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
152 | $22 | $131 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
149 | $1 | $3 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
136 | $77 | $382 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 119 | $336 | $1,325 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
116 | $1 | $6 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
91 | $15 | $70 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
75 | $49 | $235 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
75 | $136 | $376 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
71 | $2 | $5 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
69 | $3 | $15 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
61 | $25 | $194 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
59 | $10 | $97 |
| New patient office visit, complex (60-74 min) | 57 | $162 | $544 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
57 | $60 | $172 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $114 | $429 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
44 | $91 | $245 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
40 | $16 | $90 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $133 | $528 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
28 | $31 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
18 | $69 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.6% high complexity
92.6% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,747
Total received (2018-2024)
Avg $1,535/year across 7 years
Top 28% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
474
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,450
2023
$1,506
2022
$993
2021
$1,765
2020
$569
2019
$2,083
2018
$2,381
Payments by company (2024)
Gilead Sciences, Inc.
$220
ABBVIE INC.
$188
Regeneron Healthcare Solutions, Inc.
$145
Eisai Inc.
$76
Genentech USA, Inc.
$75
PFIZER INC.
$59
Alexion Pharmaceuticals, Inc.
$58
Janssen Biotech, Inc.
$57
TerSera Therapeutics LLC
$50
Merck Sharp & Dohme LLC
$49
BeiGene USA, Inc.
$47
Janssen Pharmaceuticals, Inc
$44
Novartis Pharmaceuticals Corporation
$42
Takeda Pharmaceuticals U.S.A., Inc.
$38
AstraZeneca Pharmaceuticals LP
$34
EMD Serono, Inc.
$30
CSL Behring
$30
Stemline Therapeutics Inc.
$29
Daiichi Sankyo Inc.
$26
ADC Therapeutics America, Inc.
$26
SOBI, INC
$24
SpringWorks Therapeutics, Inc.
$23
Exelixis Inc.
$19
Kyowa Kirin, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$16
SERVIER PHARMACEUTICALS LLC
$15
Dendreon Pharmaceuticals LLC
$14
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
G1 Therapeutics, Inc.
$1,500
Genentech USA, Inc.
$771
Novartis Pharmaceuticals Corporation
$675
Amgen Inc.
$655
AstraZeneca Pharmaceuticals LP
$573
Janssen Biotech, Inc.
$475
Gilead Sciences, Inc.
$414
Merck Sharp & Dohme Corporation
$350
Seattle Genetics, Inc.
$339
Regeneron Healthcare Solutions, Inc.
$332
Daiichi Sankyo Inc.
$267
Takeda Pharmaceuticals U.S.A., Inc.
$265
ABBVIE INC.
$252
Eisai Inc.
$226
PFIZER INC.
$220
Astellas Pharma US Inc
$198
Celgene Corporation
$195
E.R. Squibb & Sons, L.L.C.
$180
Seagen Inc.
$169
SOBI, INC
$149
Pharmacyclics LLC, An AbbVie Company
$143
GENZYME CORPORATION
$132
Bayer HealthCare Pharmaceuticals Inc.
$129
Merck Sharp & Dohme LLC
$125
Exelixis Inc.
$121
AbbVie, Inc.
$116
Karyopharm Therapeutics Inc.
$104
Alexion Pharmaceuticals, Inc.
$104
Lilly USA, LLC
$102
TerSera Therapeutics LLC
$94
Clovis Oncology, Inc.
$92
Rigel Pharmaceuticals, Inc.
$91
Pharmacyclics LLC, an AbbVie Company
$90
BeiGene USA, Inc.
$67
TESARO, Inc.
$66
Janssen Pharmaceuticals, Inc
$59
Lexicon Pharmaceuticals, Inc.
$54
CTI BioPharma Corp.
$54
Stemline Therapeutics Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
ADC Therapeutics America, Inc.
$49
Incyte Corporation
$42
Kite Pharma, Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$38
Helsinn Therapeutics (U.S.), Inc.
$33
GlaxoSmithKline, LLC.
$32
Mylan Pharmaceuticals Inc.
$31
SERVIER PHARMACEUTICALS LLC
$31
EMD Serono, Inc.
$30
CSL Behring
$30
ARRAY BIOPHARMA INC
$30
Advanced Accelerator Applications
$27
AMAG Pharmaceuticals, Inc.
$26
EUSA Pharma (US) LLC
$24
SpringWorks Therapeutics, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$21
Blueprint Medicines Corporation
$21
Mirati Therapeutics, Inc.
$21
Mylan Institutional Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Kyowa Kirin, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$18
Myovant Sciences Inc.
$16
INSYS Therapeutics Inc
$14
Dendreon Pharmaceuticals LLC
$14
Teva Pharmaceuticals USA, Inc.
$13
Fortovia Therapeutics, Inc.
$12
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · AKYNZEO · ALOXI · AYVAKIT · Alecensa · Aliqopa · Aranesp · Avastin · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYMBALTA · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERBITUX · Enhertu · Erleada · FASLODEX · FERAHEME · FRUZAQLA · Fulphila · GAZYVA · GILOTRIF · Gazyva · Hizentra · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MVASI · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN · SCEMBLIX · SOMATULINE DEPOT · SUBSYS · SYLVANT · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Yescarta · ZEJULA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
102
County median income
$108,986
Nearest hospital to ZIP centroid (approximate)
PIEDMONT FAYETTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lohiya is a mixed practice specialist, with above-average Medicare volume (top 7% in GA), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lohiya experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Lohiya performed 35,200 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lohiya receive payments from pharmaceutical companies?
Yes. Dr. Lohiya received a total of $10,747 from 67 companies across 474 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lohiya's costs compare to other hematology & oncology specialists in Fayetteville?
Dr. Lohiya's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lohiya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fayetteville
Browse hematology & oncology specialists in Fayetteville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
G1 Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from G1 Therapeutics, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology